Acewin Biotech India Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
- Paid Up Capital ₹ 3.30 Cr
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 94.45%
- Profit Growth 6.63%
- Ebitda 12.25%
- Net Worth 5.02%
- Total Assets 17.29%
About Acewin Biotech India
Acewin Biotech India Limited (ABIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 16 July 2012 and has a history of 12 years and seven months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Acewin Biotech India Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 3.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Irudayaraj Ignacimuthu, Amalin Baskarraj, and Xavier Austeen serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01400TN2012PLC086777
- Company No.
086777
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Jul 2012
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Acewin Biotech India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Irudayaraj Ignacimuthu  | Director | 12-Feb-2019 | Current |
| Amalin Baskarraj | Director | 12-Mar-2019 | Current |
| Xavier Austeen | Director | 15-May-2019 | Current |
Financial Performance of Acewin Biotech India.
Acewin Biotech India Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 94.45% increase. The company also saw a slight improvement in profitability, with a 6.63% increase in profit. The company's net worth moved up by a moderate rise of 5.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acewin Biotech India?
In 2019, Acewin Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sand & Sand Private LimitedXavier Austeen is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Acewin Biotech India?
Unlock and access historical data on people associated with Acewin Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acewin Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acewin Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
